{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:11:29Z","timestamp":1762906289218,"version":"3.45.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":290,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012425","name":"Beijing Children's Hospital Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.ebr.2022.100568","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T13:10:24Z","timestamp":1666185024000},"page":"100568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Acute liver failure associated with lamotrigine in children with epilepsy: A report of two cases and thoughts on pharmacogenomics"],"prefix":"10.1016","volume":"20","author":[{"given":"Jie","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-ran","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2022.100568_b0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cld.2018.06.009","article-title":"Acute liver failure: an update","volume":"22","author":"Squires","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ebr.2022.100568_b0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s40124-018-0174-7","article-title":"Management of acute liver failure: a pediatric perspective","volume":"6","author":"Bhatt","year":"2018","journal-title":"Curr Pediatr Rep"},{"issue":"5","key":"10.1016\/j.ebr.2022.100568_b0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.dld.2021.03.004","article-title":"Diagnostic approach to acute liver failure in children: a position paper by the SIGENP liver disease working group","volume":"53","author":"Di Giorgio","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ebr.2022.100568_b0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.311.7000.292b","article-title":"Fulminant hepatic failure induced by lamotrigine","volume":"311","author":"Makin","year":"1995","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ebr.2022.100568_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0887-8994(97)00196-3","article-title":"Acute hepatic failure in a child treated with lamotrigine","volume":"18","author":"Arnon","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ebr.2022.100568_b0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/SMJ.0b013e3181878b95","article-title":"Fulminant hepatitis induced by Lamotrigine","volume":"102","author":"Ouellet","year":"2009","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.ebr.2022.100568_b0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ebr.2022.100568_b0040","unstructured":"Lamotrigine. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"year":"2016","series-title":"Pediatric & neonatal dosage handbook","author":"Taketomo","key":"10.1016\/j.ebr.2022.100568_b0045"},{"key":"10.1016\/j.ebr.2022.100568_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2019.08.003","article-title":"Genetic predisposition to drug-induced liver injury","volume":"24","author":"Stephens","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ebr.2022.100568_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/17425255.2021.1854726","article-title":"Genetic risk factors in the development of idiosyncratic drug-induced liver injury","volume":"17","author":"Stephens","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ebr.2022.100568_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2017.01.014","article-title":"Pharmacogenomics in epilepsy","volume":"667","author":"Balestrini","year":"2018","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.ebr.2022.100568_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FPC.0000000000000397","article-title":"PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics","volume":"30","author":"Mitra-Ghosh","year":"2020","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ebr.2022.100568_b0070","article-title":"Association between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 polymorphisms and responsiveness to antiepileptic drugs: a meta-analysis","volume":"11","author":"Li","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebr.2022.100568_b0075","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00228-014-1690-1","article-title":"Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China","volume":"70","author":"Chang","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ebr.2022.100568_b0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.dmpk.2015.05.002","article-title":"Polymorphisms of ABCG2, ABCB1 and HNF4\u03b1 are associated with Lamotrigine trough concentrations in epilepsy patients","volume":"30","author":"Zhou","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ebr.2022.100568_b0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eplepsyres.2016.09.004","article-title":"Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy","volume":"127","author":"Shen","year":"2016","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.ebr.2022.100568_b0090","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41397-020-0173-2","article-title":"Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy","volume":"20","author":"Ortega-V\u00e1zquez","year":"2020","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"10.1016\/j.ebr.2022.100568_b0095","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/FPC.0b013e3283117d67","article-title":"Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression","volume":"18","author":"Kwan","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ebr.2022.100568_b0100","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00228-012-1449-5","article-title":"Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients","volume":"69","author":"Singkham","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ebr.2022.100568_b0105","first-page":"439","article-title":"Interethnic differences in UGT1A4 genetic polymorphisms and its effect on lamotrigine trough concentrations","volume":"31","author":"Zhou","year":"2015","journal-title":"Chin J Clin Pharmacol"},{"key":"10.1016\/j.ebr.2022.100568_b0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/tan.13530","article-title":"HLA-associated antiepileptic drug-induced cutaneous adverse reactions","volume":"93","author":"Mullan","year":"2019","journal-title":"HLA"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986422000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986422000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:07:44Z","timestamp":1762906064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986422000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":22,"alternative-id":["S2589986422000454"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2022.100568","relation":{},"ISSN":["2589-9864"],"issn-type":[{"type":"print","value":"2589-9864"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute liver failure associated with lamotrigine in children with epilepsy: A report of two cases and thoughts on pharmacogenomics","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2022.100568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100568"}}